Human Hepatic Flavin-Containing Monooxygenases 1 (FMO1) and 3 (FMO3) Developmental Expression

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961 · see citing works

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.76.9.4350 · Cited by 51,421 · see citing works

Measurement of protein using bicinchoninic acid

Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482 · see citing works

Expression of CYP3A in the Human Liver — Evidence that the Shift between CYP3A7 and CYP3A4 Occurs Immediately After Birth

Lacroix, D. A., Sonnier, M., Moncion, A., Chéron, G., & Cresteil, T. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00625.x · Cited by 537 · see citing works

Glucuronidation in Humans

de Wildt, S. N., KEARNS, G., Leeder, J. S., & van den Anker, J. N. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00005 · Cited by 392 · see citing works

Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes

Lang, D., Yeung, C., Peter, R., Ibarra, C., Gasser, R., Itagaki, K., Philpot, R., & Rettie, A. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00218-4 · Cited by 303 · see citing works

Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome

Dolphin, C. T., Janmohamed, A., Smith, R. L., Shephard, E. A., & Phillips, L. R. (1997) · Nature Genetics · doi:10.1038/ng1297-491 · Cited by 284 · see citing works

Effects of Freezing, Thawing, and Storing Human Liver Microsomes on Cytochrome P450 Activity

Pearce, R. E., McIntyre, C. J., Madan, A., Sanzgiri, U. Y., Draper, A. J., Bullock, P. L., Cook, D. C., Burton, L. A., Latham, J., Nevins, C., et al. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0294 · Cited by 253 · see citing works

Recent Studies on the Structure and Function of Multisubstrate Flavin-Containing Monooxygenases

Ziegler, D. M. (1993) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.001143 · Cited by 248 · see citing works

Microsomal Flavin-Containing Monooxygenase: Oxygenation of Nucleophilic Nitrogen and Sulfur Compounds

Ziegler, D. M. (1980) · Elsevier eBooks · doi:10.1016/b978-0-12-380001-5.50015-3 · Cited by 236 · see citing works

Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication

Treacy, E. P. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.839 · Cited by 228 · see citing works

Structural and Catalytic Properties of the Mammalian Flavin-Containing Monooxygenase

Cashman, J. R. (1995) · Chemical Research in Toxicology · doi:10.1021/tx00044a001 · Cited by 227 · see citing works

Hormonal regulation of rat liver microsomal enzymes. Role of gonadal steroids in programming, maintenance, and suppression of delta 4-steroid 5 alpha-reductase, flavin-containing monooxygenase, and sex-specific cytochromes P-450.

Dannan, G. A., Guengerich, F. P., & Waxman, D. J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67446-0 · Cited by 167 · see citing works

Differential Developmental and Tissue‐Specific Regulation of Expression of the Genes Encoding Three Members of the Flavin‐Containing Monooxygenase Family of Man, FMO1, FMO3 and FMO4

Dolphin, C. T., Cullingford, T. E., Shcphard, E. A., Smith, R. L., & Phillips, I. R. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00683.x · Cited by 152 · see citing works

Quantitation and kinetic properties of hepatic microsomal and recombinant flavin-containing monooxygenases 3 and 5 from humans

Overby, L. H., Carver, G. C., & Philpot, R. M. (1997) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00055-0 · Cited by 145 · see citing works

Immunoquantitation of FMO1 in Human Liver, Kidney, and Intestine

Yeung, C. K., Lang, D. H., Thummel, K. E., & Rettie, A. E. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15194-x · Cited by 130 · see citing works

Benzydamine N‐oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity

Störmer, E., Roots, I., & Brockmöller, J. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00296.x · Cited by 119 · see citing works

Mild trimethylaminuria caused by common variants in FM03 gene

Zschocke, J., Kohlmueller, D., Quak, E., Meißner, T., Hoffmann, G. F., & Mayatepek, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)80019-1 · Cited by 109 · see citing works

Cytochrome P-450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA.

Frederick, C. B., Mays, J. B., Ziegler, D. M., Guengerich, F. P., & Kadlubar, F. F. (1982) · PubMed · Cited by 100 · see citing works

The Involvement of Flavin-Containing Monooxygenase but Not CYP3A4 in Metabolism of Itopride Hydrochloride, a Gastroprokinetic Agent: Comparison with Cisapride and Mosapride Citrate

Mushiroda, T., Douya, R., Takahara, E., & Nagata, O. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0026-895x(24)12055-x · Cited by 98 · see citing works

Flavin Adenine Dinucleotide—Dependent Monooxygenase: Its Role in the Sulfoxidation of Pesticides in Mammals

Hajjar, N. P., & Hodgson, E. (1980) · Science · doi:10.1126/science.7403873 · Cited by 96 · see citing works

Multisubstrate flavin-containing monooxygenases: applications of mechanism to specificity

Poulsen, L. L., & Ziegler, D. M. (1995) · Chemico-Biological Interactions · doi:10.1016/0009-2797(94)03583-t · Cited by 93 · see citing works

In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles

Cashman, J. R., Xiong, Y., Lin, J., Verhagen, H., van Poppel, G., van Bladeren, P. J., Larsen-Su, S., & Williams, D. E. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00166-5 · Cited by 93 · see citing works

Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis.

Yang, H., Lee, Q. P., Rettie, A. E., & Juchau, M. R. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09834-7 · Cited by 86 · see citing works

Ethnic Differences in Human Flavin-Containing Monooxygenase 2 (FMO2) Polymorphisms: Detection of Expressed Protein in African-Americans

Whetstine, J. R., Yueh, M., Hopp, K. A., McCarver, D. G., Williams, D. E., Park, C., Kang, J., Cha, Y.-N., Dolphin, C. T., Shephard, E. A., et al. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.9050 · Cited by 85 · see citing works

Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.

Cashman, J. R., PARK, S. B., Yang, Z., Washington, C. B., Gomez, D. Y., Giacomini, K. M., & Brett, C. M. A. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07460-4 · Cited by 83 · see citing works

Regulation of Mouse Liver Flavin-Containing Monooxygenases 1 and 3 by Sex Steroids

Falls, J. G., Ryu, D., Cao, Y., Levi, P. E., & Hodgson, E. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.9965 · Cited by 83 · see citing works

Physiological factors affecting protein expression of flavin-containing monooxygenases 1, 3 and 5

Cherrington, N. J., Cao, Y., Cherrington, J. W., Rose, R. L., & Hodgson, E. (1998) · Xenobiotica · doi:10.1080/004982598239254 · Cited by 82 · see citing works

Temporal Expression of the Human Alcohol Dehydrogenase Gene Family during Liver Development Correlates with Differential Promoter Activation by Hepatocyte Nuclear Factor 1, CCAAT/Enhancer-Binding Protein α, Liver Activator Protein, and D-Element-Binding Protein

van Ooij, C., Snyder, R. C., Paeper, B. W., & Duester, G. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.7.3023 · Cited by 81 · see citing works

Molecular cloning of the flavin-containing monooxygenase (form II) cDNA from adult human liver.

Lomri, N., Gu, Q., & Cashman, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9910 · Cited by 80 · see citing works

Trimethylaminuria Is Caused by Mutations of the FMO3 Gene in a North American Cohort

Akerman, B. R., Lemass, H., Chow, L. M. L., Lambert, D. M., Greenberg, C. R., Bibeau, C., Mamer, O., & Treacy, E. P. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2885 · Cited by 78 · see citing works

Oxidation of Ranitidine by Isozymes of Flavin-Containing Monooxygenase and Cytochrome P450

Chung, W., Park, C., Roh, H., Lee, W.-K., & Cha, Y. (2000) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.84.213 · Cited by 78 · see citing works

Tissue- and species-dependent expression of multiple forms of mammalian microsomal flavin-containing monooxygenase.

Tynes, R. E., & Philpot, R. M. (1987) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10470-7 · Cited by 71 · see citing works

Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations.

Cashman, J. R., & Ziegler, D. M. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10184-3 · Cited by 67 · see citing works

Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit.

Shehin, S. E., Williams, D. E., Larsen-Su, S. A., Stresser, D. M., & Hines, R. N. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24559-1 · Cited by 65 · see citing works

Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FMO3) gene in patients with fish-odour syndrome

Dolphin, C. T., Janmohamed, A., Smith, R. L., Shephard, E. A., & Phillips, I. R. (2000) · Pharmacogenetics · doi:10.1097/00008571-200012000-00005 · Cited by 64 · see citing works

Stereoselective sulfoxidation by human flavin-containing monooxygenase. Evidence for catalytic diversity between hepatic, renal, and fetal forms.

Sadeque, A. J. M., Eddy, A. C., Meier, G. P., & Rettie, A. E. (1992) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08803-8 · Cited by 64 · see citing works

Human Flavin-Containing Monooxygenase Form 3: cDNA Expression of the Enzymes Containing Amino Acid Substitutions Observed in Individuals with Trimethylaminuria

Cashman, J. R., Bi, Y., Lin, J., Youil, R., Knight, M. A., Forrest, S., & Treacy, E. P. (1997) · Chemical Research in Toxicology · doi:10.1021/tx9700533 · Cited by 63 · see citing works

Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FMO3 gene mutations in a Korean population

Kang, J., Chung, W., Lee, K., Park, C., Kang, J., Shin, I., Roh, H., Dong, M., Baek, H.-M., & Cha, Y. (2000) · Pharmacogenetics · doi:10.1097/00008571-200002000-00009 · Cited by 63 · see citing works

Molecular cloning of the flavin-containing monooxygenase (form II) cDNA from adult human liver.

Lomri, N., Gu, Q., & Cashman, J. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1685 · Cited by 60 · see citing works

In vitro-in vivo correlations of human (s)-nicotine metabolism

Berkman, C. E., Park, S. B., Wrighton, S. A., & Cashman, J. R. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00168-y · Cited by 57 · see citing works

Transient trimethylaminuria in childhood

Mayatepek, D. K. E., & Kohlmüller, D. (1998) · Acta Paediatrica · doi:10.1080/080352598750031257 · Cited by 54 · see citing works

Flavin-Containing Monooxygenase Activity in Human Liver Microsomes

McManus, M. E., Birkett, D., Burgess, W. M., Stupans, I., Koenig, J., Boobis, A. R., Davies, D. S., Wirth, P. J., Grantham, P. H., & Thorgeirsson, S. S. (1986) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5134-4_72 · Cited by 50 · see citing works

Dietary indole-3-carbinol inhibits FMO activity and the expression of flavin-containing monooxygenase form 1 in rat liver and intestine.

Larsen-Su, S. A., & Williams, D. E. J. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07485-9 · Cited by 46 · see citing works

Purification of macacque liver flavin-containing monooxygenase: A form of the enzyme related immunochemically to an isozyme expressed selectively in adult human liver

Sadeque, A. J. M., Thummel, K. E., & Rettie, A. E. (1993) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(93)90138-h · Cited by 45 · see citing works

Two novel mutations of theFMO3 gene in a proband with trimethylaminuria

Akerman, B. R., Forrest, S. M., Chow, L., Youil, R., Knight, M. A., & Treacy, E. P. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)13:5 · Cited by 45 · see citing works

Changes in Dimethylaniline N-Oxidase Activity of Mouse Liver and Kidney Induced by Steroid Sex Hormones

Duffel, M. W., GRAHAM, J. M., & Dm, Z. (1981) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12522-4 · Cited by 44 · see citing works

Induction of Flavin-Containing Monooxygenase (FMO B) in Rabbit Lung and Kidney by Sex Steroids and Glucocorticoids

Lee, M. Y., Clark, J. E., & Williams, D. E. J. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1219 · Cited by 43 · see citing works

Role of the liver-enriched transcription factors C/EBPα and DBP in the expression of human CYP3A4 and CYP3A7

Ourlin, J.-C., Jounaïdi, Y., Maurel, P., & Vilarem, M. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80497-7 · Cited by 42 · see citing works

Hormonal regulation of microsomal flavin-containing monooxygenase activity by sex steroids and growth hormone in co-cultured adult male rat hepatocytes

Coecke, S., Debast, G., Phillips, I. R., Vercruysse, A., Shephard, E. A., & Rogiers, V. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00104-x · Cited by 42 · see citing works

Potential role of the flavin-containing monooxygenases in the metabolism of endogenous compounds

Elfarra, A. A. (1995) · Chemico-Biological Interactions · doi:10.1016/0009-2797(94)03582-s · Cited by 41 · see citing works

A novel mutation in the flavin-containing monooxygenase 3 gene, FMO3, that causes fish-odour syndrome: activity of the mutant enzyme assessed by proton NMR spectroscopy

Murphy, H. C., Dolphin, C. T., Janmohamed, A., HOLMES, H. C., Michelakakis, H., Shephard, E. A., CHALMERS, R. A., Phillips, I. R., & Iles, R. A. (2000) · Pharmacogenetics · doi:10.1097/00008571-200007000-00007 · Cited by 41 · see citing works

Effect of pregnancy or treatment with cetain steroids on N,N-dimethylaniline demethylation and N-oxidation by rabbit liver or lung microsomes.

Devereux, T. R., & Fouts, J. R. (1975) · PubMed · Cited by 41 · see citing works

Flavin-containing monooxygenase mediated metabolism of psychoactive drugs by human brain microsomes

Bhamre, S., Bhagwat, S. V., Shankar, S. K., Boyd, M. R., & Ravindranath, V. (1995) · Brain Research · doi:10.1016/0006-8993(94)01135-5 · Cited by 39 · see citing works

Localization of glutathione S-transferases alpha and pi in human embryonic tissues at 8 weeks gestational age

Lieshout, E. M. M. V., Knapen, M. F. C. M., Lange, W., Steegers, E. A. P., & Peters, W. H. M. (1998) · Human Reproduction · doi:10.1093/humrep/13.5.1380 · Cited by 37 · see citing works

Transient trimethylaminuria in childhood

Mayatepek, E., & Kohlmüller, D. (1998) · Acta Paediatrica · doi:10.1111/j.1651-2227.1998.tb00934.x · Cited by 37 · see citing works

Localization of Human Flavin-Containing Monooxygenase GenesFMO2andFMO5to Chromosome 1q

McCombie, R. R., Dolphin, C. T., Povey, S., Phillips, I. R., & Shephard, E. A. (1996) · Genomics · doi:10.1006/geno.1996.0308 · Cited by 35 · see citing works

Localization of Genes Encoding Three Distinct Flavin-Containing Monooxygenases to Human Chromosome 1q

Shephard, E. A., Dolphin, C. T., Fox, M., Povey, S., Smith, R. M., & Phillips, I. R. (1993) · Genomics · doi:10.1006/geno.1993.1144 · Cited by 35 · see citing works

Phenotyping of flavin-containing monooxygenase using caffeine metabolism and genotyping of FMO3 gene in a Korean population.

Cs, P., Wg, C., Jh, K., Hk, R., Kh, L., & Cha, Y. N. (1999) · PubMed · Cited by 32 · see citing works

Regulation of Flavin-Containing Monooxygenase 1 Expression by Ying Yang 1 and Hepatic Nuclear Factors 1 and 4

Luo, Z., & Hines, R. N. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1421 · Cited by 31 · see citing works

Cellular Localization of Flavin-Containing Monooxygenase in Rabbit Lung

Overby, L. H., Nishio, S. J., Lawton, M. P., Plopper, C. G., & Philpot, R. M. (1992) · Experimental Lung Research · doi:10.3109/01902149209020656 · Cited by 26 · see citing works

Molecular regulation of genes encoding xenobiotic-metabolizing enzymes: mechanisms involving endogenous factors.

Hines, R. N., Luo, Z., Cresteil, T., Ding, X., Prough, R. A., Fitzpatrick, J. L., Ripp, S. L., Falkner, K. C., Ge, N. L., Levine, A., et al. (2001) · PubMed · Cited by 24 · see citing works

Oxidation of desmethylpromethazine catalyzed by pig liver flavin-containing monooxygenase. Number and nature of metabolites.

Clement, B., Lustig, K., & Ziegler, D. M. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07331-3 · Cited by 18 · see citing works

Tertiary Amines Related to Brompheniramine: Preferred Conformations for N-Oxygenation by the Hog Liver Flavin-Containing Monooxygenase

Cashman, J. R., Celestial, J. R., Leach, A. R., Newdoll, J., & Park, S. B. (1993) · Pharmaceutical Research · doi:10.1023/a:1018947714030 · Cited by 13 · see citing works

The flavin-containing monooxygenase system

Gasser, R. (1996) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(96)80057-1 · Cited by 13 · see citing works

Galactosamine decreases nitric oxide formation in cultured rat hepatocytes: Lack of involvement in cytotoxicity

McMillan, J. (1999) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/(sici)1099-0461(1999)13:3/4 · Cited by 4 · see citing works

Clinical biomarkers in drug discovery and development

Frank, R. A., & Hargreaves, R. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1130 · Cited by 794 · see citing works

Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism

Krueger, S. K., & Williams, D. E. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.01.001 · Cited by 570 · see citing works

Trimethylamine <i>N</i> -Oxide, the Microbiome, and Heart and Kidney Disease

Zeisel, S. H., & Warrier, M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064732 · Cited by 475 · see citing works

The ontogeny of drug metabolism enzymes and implications for adverse drug events

Hines, R. N. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.005 · Cited by 408 · see citing works

Developmental Expression of the Major Human Hepatic CYP3A Enzymes

Stevens, J. C., Hines, R. N., Gu, C., Koukouritaki, S. B., Manro, J. R., Tandler, P. J., & Zaya, M. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054841 · Cited by 368 · see citing works

Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease

Fennema, D., Phillips, I. R., & Shephard, E. A. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.070615 · Cited by 355 · see citing works

The Ontogeny of Human Drug-Metabolizing Enzymes: Phase I Oxidative Enzymes

Hines, R. N., & McCarver, D. G. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.355 · Cited by 364 · see citing works

Developmental Pharmacokinetics in Pediatric Populations

Lu, H., & Rosenbaum, S. (2014) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-19.4.262 · Cited by 358 · see citing works

HUMAN FLAVIN-CONTAINING MONOOXYGENASES

Cashman, J. R., & Zhang, J. (2006) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141043 · Cited by 333 · see citing works

Developmental Expression of Human Hepatic CYP2C9 and CYP2C19

Koukouritaki, S. B., Manro, J. R., Marsh, S. A., Stevens, J. C., Rettie, A. E., McCarver, D. G., & Hines, R. N. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060137 · Cited by 327 · see citing works

Metabolism of Xenobiotics of Human Environments

Croom, E. L. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-415813-9.00003-9 · Cited by 230 · see citing works

Impact of endocrine-disrupting compounds (EDCs) on female reproductive health

Fowler, P., Bellingham, M., Sinclair, K. D., Evans, N. P., Pocar, P., Fischer, B., Schaedlich, K., Schmidt, J., Amezaga, M. R., Bhattacharya, S., et al. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.021 · Cited by 228 · see citing works

Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis

Chitnis, T., Tenembaum, S. N., Banwell, B., Krupp, L., Pohl, D., Rostasy, K. M., Yeh, E. A., Быкова, О. В., Wassmer, E., Tardieu, M., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511430704 · Cited by 219 · see citing works

Ontogeny of drug metabolizing enzymes in the neonate

Blake, M. J., Castro, L., Leeder, J. S., & Kearns, G. L. (2005) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2004.11.001 · Cited by 200 · see citing works

Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children.

Hines, R. (2013) · International journal of pharmaceutics · doi:10.1016/j.ijpharm.2012.05.079 · Cited by 160 · see citing works

Organization and evolution of the flavin-containing monooxygenase genes of human and mouse

Hernandez, D., Janmohamed, A., Chandan, P., Phillips, I. R., & Shephard, E. A. (2004) · Pharmacogenetics · doi:10.1097/00008571-200402000-00006 · Cited by 173 · see citing works

Human Hepatic CYP2E1 Expression during Development

Johnsrud, E. K., Koukouritaki, S. B., Divakaran, K., Brunengraber, L. L., Hines, R. N., & McCarver, D. G. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053124 · Cited by 169 · see citing works

Developmental Changes in Human Liver CYP2D6 Expression

Stevens, J. C., Marsh, S. A., Zaya, M. J., Regina, K. J., Divakaran, K., Le, M., & Hines, R. N. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021873 · Cited by 163 · see citing works

Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations

Benedetti, M. S., Whomsley, R., & Baltes, E. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.3.447 · Cited by 151 · see citing works

QUANTITATIVE ANALYSIS OF FMO GENE mRNA LEVELS IN HUMAN TISSUES

Zhang, J., & Cashman, J. R. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006171 · Cited by 144 · see citing works

Flavin-containing monooxygenases: mutations, disease and drug response

Phillips, I. R., & Shephard, E. A. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.03.004 · Cited by 141 · see citing works

Isolation of pigment cell specific genes in the sea urchin embryo by differential macroarray screening

Calestani, C., Rast, J. P., & Davidson, E. H. (2003) · Development · doi:10.1242/dev.00647 · Cited by 137 · see citing works

Paediatric oral biopharmaceutics: key considerations and current challenges.

Batchelor, H., Fotaki, N., & Klein, S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.10.006 · Cited by 125 · see citing works

Cell-, tissue-, sex- and developmental stage-specific expression of mouse flavin-containing monooxygenases (Fmos)

Janmohamed, A., Hernandez, D., Phillips, I. R., & Shephard, E. A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.02.036 · Cited by 121 · see citing works

Drug metabolism by flavin-containing monooxygenases of human and mouse

Phillips, I. R., & Shephard, E. A. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1239718 · Cited by 111 · see citing works

Xenobiotic metabolism gene expression in the EpiDerm™ in vitro 3D human epidermis model compared to human skin

Hu, T., Khambatta, Z. S., Hayden, P. J., Bolmarcich, J., Binder, R. L., Robinson, M. K., Carr, G. J., Tiesman, J. P., Jarrold, B. B., Osborne, R., et al. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.03.013 · Cited by 110 · see citing works

Interindividual Differences of Human Flavin-Containing Monooxygenase 3: Genetic Polymorphisms and Functional Variation

Cashman, J. R., & Zhang, J. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.10.1043 · Cited by 109 · see citing works

Developmental Expression of Aryl, Estrogen, and Hydroxysteroid Sulfotransferases in Pre- and Postnatal Human Liver

Duanmu, Z., Weckle, A. L., Koukouritaki, S. B., Hines, R. N., Falany, J. L., Falany, C. N., Kocarek, T. A., & Runge‐Morris, M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093633 · Cited by 106 · see citing works

Human hepatic CYP2B6 developmental expression: The impact of age and genotype

Croom, E. L., Stevens, J. C., Hines, R. N., Wallace, A. D., & Hodgson, E. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.029 · Cited by 98 · see citing works

Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics

Benedetti, M. S., Whomsley, R., & Baltes, E. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.895 · Cited by 96 · see citing works

Pediatric Pharmacokinetic Data: Implications for Environmental Risk Assessment for Children

Ginsberg, G., Hattis, D. B., Miller, R. K., & Sonawane, B. R. (2004) · PEDIATRICS · doi:10.1542/peds.113.s3.973 · Cited by 96 · see citing works

Trimethylaminuria: causes and diagnosis of a socially distressing condition.

Mackay, R. J., McEntyre, C. J., Henderson, C., Lever, M., & George, P. M. (2011) · Europe PMC (PubMed Central) · Cited by 94 · see citing works

Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3'-Diindolylmethane

Williams, D. E. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.734334 · Cited by 92 · see citing works

Epirubicin Glucuronidation and UGT2B7 Developmental Expression

Zaya, M. J., Hines, R. N., & Stevens, J. C. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011387 · Cited by 92 · see citing works

Alternative Processing of the Human FMO6 Gene Renders Transcripts Incapable of Encoding a Functional Flavin-Containing Monooxygenase

Hines, R. N., Hopp, K. A., Franco, J., Saeian, K., & Begun, F. P. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.320 · Cited by 88 · see citing works

Flavin-Containing Monooxygenase 1 Catalyzes the Production of Taurine from Hypotaurine

Veeravalli, S., Phillips, I. R., Freire, R. T., Varshavi, D., Everett, J. R., & Shephard, E. A. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.089995 · Cited by 85 · see citing works

Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism

Schulz, J., Kluwe, F., Mikus, G., Michelet, R., & Kloft, C. (2019) · Drug Metabolism Reviews · doi:10.1080/03602532.2019.1632888 · Cited by 83 · see citing works

Flavin-containing monooxygenases in aging and disease: Emerging roles for ancient enzymes

Rossner, R., Kaeberlein, M. R., & Leiser, S. F. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.779678 · Cited by 80 · see citing works

Role of flavin-containing monooxgenase in drug development

Cashman, J. R. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250802522188 · Cited by 79 · see citing works

Human Kidney Flavin-Containing Monooxygenases and Their Potential Roles in Cysteine S-Conjugate Metabolism and Nephrotoxicity

Krause, R. J., Lash, L. H., & Elfarra, A. A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042911 · Cited by 79 · see citing works

A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia

Kadan‐Lottick, N. S., Brouwers, P. Y., Breiger, D., Kaleita, T. A., Dziura, J., Liu, H., Chen, L., Nicoletti, M., Stork, L. C., Bostrom, B., et al. (2009) · Blood · doi:10.1182/blood-2008-12-186502 · Cited by 78 · see citing works

Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxide

Siddens, L. K., Krueger, S. K., Henderson, M. C., & Williams, D. E. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.02.006 · Cited by 75 · see citing works

Specific features of pharmacokinetics in children

Matalová, P., Urbánek, K., & Anzenbacher, P. (2016) · Drug Metabolism Reviews · doi:10.3109/03602532.2015.1135941 · Cited by 73 · see citing works

Trimethylamine N -oxide: heart of the microbiota–CVD nexus?

Naghipour, S., Cox, A. J., Peart, J. N., Toit, E. F. D., & Headrick, J. P. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422420000177 · Cited by 75 · see citing works

The implications of polymorphisms in mammalian flavin-containing monooxygenases in drug discovery and development

Cashman, J. R. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03136-8 · Cited by 71 · see citing works

Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1, FMO2 and FMO3 and mouse and human lung microsomes

Henderson, M. C., Siddens, L. K., Morré, J. T., Krueger, S. K., & Williams, D. E. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.09.017 · Cited by 71 · see citing works

Flavin-containing monooxygenase 3 (FMO3): genetic variants and their consequences for drug metabolism and disease

Phillips, I. R., & Shephard, E. A. (2019) · Xenobiotica · doi:10.1080/00498254.2019.1643515 · Cited by 71 · see citing works

TWO NEW POLYMORPHISMS OF THE FMO3 GENE IN CAUCASIAN AND AFRICAN-AMERICAN POPULATIONS: COMPARATIVE GENETIC AND FUNCTIONAL STUDIES

Lattard, V., Zhang, J., Tran, Q., Furnes, B., Schlenk, D., & Cashman, J. R. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.7.854 · Cited by 71 · see citing works

Discovery of Novel Flavin-Containing Monooxygenase 3 (FMO3) Single Nucleotide Polymorphisms and Functional Analysis of Upstream Haplotype Variants

Koukouritaki, S. B., Poch, M. T., Cabacungan, E., McCarver, D. G., & Hines, R. N. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012062 · Cited by 69 · see citing works

Identification and Functional Analysis of Common Human Flavin-Containing Monooxygenase 3 Genetic Variants

Koukouritaki, S. B., Poch, M. T., Henderson, M. C., Siddens, L. K., Krueger, S. K., VanDyke, J. E., Williams, D. E., Pajewski, N. M., Wang, T., & Hines, R. N. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112268 · Cited by 69 · see citing works

Identification of Novel Variants of the Flavin-Containing Monooxygenase Gene Family in African Americans

Furnes, B., Feng, J., Sommer, S. S., & Schlenk, D. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.2.187 · Cited by 67 · see citing works

Maternal Smoking and Fetal Sex Significantly Affect Metabolic Enzyme Expression in the Human Fetal Liver

O’Shaughnessy, P. J., Monteiro, A., Bhattacharya, S., & Fowler, P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1437 · Cited by 66 · see citing works

Reaction Phenotyping: Current Industry Efforts to Identify Enzymes Responsible for Metabolizing Drug Candidates

Harper, T. W., & Brassil, P. J. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9019-6 · Cited by 64 · see citing works

Sources of Interindividual Variability

Thummel, K. E., & Lin, Y. S. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-758-7_17 · Cited by 65 · see citing works

Role of biokinetics in risk assessment of drugs and chemicals in children

de Zwart, L. L., Haenen, H. E. M. G., Versantvoort, C. H. M., Wolterink, G., van Engelen, J. G. M., & Sips, A. J. A. M. (2004) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2004.02.006 · Cited by 63 · see citing works

Childhood Brain Tumors, Residential Insecticide Exposure, and Pesticide Metabolism Genes

Nielsen, S. S., McKean‐Cowdin, R., Farin, F. M., Holly, E. A., Preston‐Martin, S., & Mueller, B. A. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0901226 · Cited by 62 · see citing works

Human Flavin-Containing Monooxygenase (form 3): Polymorphisms and Variations In Chemical Metabolism

Cashman, J. R. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.3.325 · Cited by 60 · see citing works

Flavin-Containing Monooxygenase Genetic Polymorphism: Impact on Chemical Metabolism and Drug Development

Koukouritaki, S. B., & Hines, R. N. (2005) · Pharmacogenomics · doi:10.2217/14622416.6.8.807 · Cited by 60 · see citing works

Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies

Saghir, S. A., Khan, S. A., & McCoy, A. T. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.674100 · Cited by 59 · see citing works

The Biochemistry of Drug Metabolism – An Introduction

Krämer, S. D., & Testa, B. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890214 · Cited by 59 · see citing works

Cytochrome P450 and flavin-containing monooxygenase families: age-dependent differences in expression and functional activity

Zane, N. R., Chen, Y., Wang, M. Z., & Thakker, D. R. (2017) · Pediatric Research · doi:10.1038/pr.2017.226 · Cited by 57 · see citing works

The Role of Flavin-Containing Monooxygenase (FMO) in the Metabolism of Tamoxifen and Other Tertiary Amines

Krueger, S. K., VanDyke, J. E., Williams, D. E., & Hines, R. N. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600569919 · Cited by 57 · see citing works

Evaluation of Xenobiotic N- and S-Oxidation by Variant Flavin-Containing Monooxygenase 1 (FMO1) Enzymes

Furnes, B. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh079 · Cited by 56 · see citing works

Age-Dependent Human Hepatic Carboxylesterase 1 (CES1) and Carboxylesterase 2 (CES2) Postnatal Ontogeny

Hines, R. N., Simpson, P. M., & McCarver, D. G. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.068957 · Cited by 56 · see citing works

Psychosocial support of the pediatric cancer patient: Lessons learned over the past 50 years

Askins, M. A., & Moore, B. D. (2008) · Current Oncology Reports · doi:10.1007/s11912-008-0072-1 · Cited by 54 · see citing works

Genetic and Nongenetic Factors Associated with Protein Abundance of Flavin-Containing Monooxygenase 3 in Human Liver

Xu, M., Bhatt, D. K., Yeung, C. K., Claw, K. G., Chaudhry, A. S., Gaedigk, A., Pearce, R. E., Broeckel, U., Gaedigk, R., Nickerson, D. A., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.243113 · Cited by 54 · see citing works

Essentials for starting a pediatric clinical study (1): Pharmacokinetics in children

Yokoi, T. (2009) · The Journal of Toxicological Sciences · doi:10.2131/jts.34.sp307 · Cited by 49 · see citing works

Human arylacetamide deacetylase hydrolyzes ketoconazole to trigger hepatocellular toxicity

Fukami, T., Iida, A., Konishi, K., & Nakajima, M. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.07.007 · Cited by 49 · see citing works

Human Hepatic UGT2B15 Developmental Expression

Divakaran, K., Hines, R. N., & McCarver, D. G. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu126 · Cited by 47 · see citing works

Model‐Based Drug–Drug Interaction Extrapolation Strategy From Adults to Children: Risdiplam in Pediatric Patients With Spinal Muscular Atrophy

Cleary, Y., Gertz, M., Grimsey, P., Günther, A., Heinig, K., Ogungbenro, K., Aarons, L. J., Galetin, A., & Kletzl, H. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2384 · Cited by 46 · see citing works

The phenotype of a flavin-containing monooyxgenase knockout mouse implicates the drug-metabolizing enzyme FMO1 as a novel regulator of energy balance

Veeravalli, S., Omar, B. A., Houseman, L., Hancock, M., Malagon, S. G. G., Scott, F. H., Janmohamed, A., Phillips, I. R., & Shephard, E. A. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.04.007 · Cited by 44 · see citing works

Human Flavin-Containing Monooxygenase 2.1 Catalyzes Oxygenation of the Antitubercular Drugs Thiacetazone and Ethionamide

Francois, A. A., Nishida, C. R., de Montellano, P. R. O., Phillips, I. R., & Shephard, E. A. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024158 · Cited by 45 · see citing works

Recent advances in the ontogeny of drug disposition

Chapron, B. D., Chapron, A., & Leeder, J. S. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14821 · Cited by 44 · see citing works

Perinatal Hypercholesterolemia Exacerbates Atherosclerosis Lesions in Offspring by Altering Metabolism of Trimethylamine-N-Oxide and Bile Acids

Trenteseaux, C., Gaston, A., Aguesse, A., Poupeau, G., de Coppet, P., Andriantsitohaina, R., Khallou‐Laschet, J., Amarger, V., Krempf, M., Nobécourt, E., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309923 · Cited by 43 · see citing works

Genetic Variability at the Human FMO1 Locus: Significance of a Basal Promoter Yin Yang 1 Element Polymorphism (FMO1*6)

Hines, R. N., Luo, Z., Hopp, K. A., Cabacungan, E., Koukouritaki, S. B., & McCarver, D. G. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053686 · Cited by 43 · see citing works

Benzydamine N-oxygenation as an index for flavin-containing monooxygenase activity and benzydamine N-demethylation by cytochrome P450 enzymes in liver microsomes from rats, dogs, monkeys, and humans

Taniguchi-Takizawa, T., Shimizu, M., Kume, T., & Yamazaki, H. (2014) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2014.09.006 · Cited by 42 · see citing works

Use of dietary phytochemicals for inhibition of trimethylamine N-oxide formation

Iglesias‐Carres, L., Hughes, M. D., Steele, C. N., Ponder, M. A., Davy, K. P., & Neilson, A. P. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108600 · Cited by 42 · see citing works

Developmental Changes of Aldehyde Oxidase Activity in Young Japanese Children

Tayama, Y., Miyake, K., Sugihara, K., Kitamura, S., Kobayashi, M., Morita, S., Ohta, S., & Kihira, K. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100078 · Cited by 42 · see citing works

Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3

Hines, R. N. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.1.41 · Cited by 42 · see citing works

Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population

Yamazaki, H., Fujita, H., Gunji, T., Zhang, J., Kamataki, T., Cashman, J. R., & Shimizu, M. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.08.008 · Cited by 40 · see citing works

Genetic Polymorphisms of Human Flavin-Containing Monooxygenase 3: Implications for Drug Metabolism and Clinical Perspectives

Hisamuddin, I. M., & Yang, V. W. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.6.635 · Cited by 38 · see citing works

Alternative promoters and repetitive DNA elements define the species-dependent tissue-specific expression of theFMO1genes of human and mouse

Shephard, E. A., Chandan, P., Stevanovic-Walker, M., Edwards, M., & Phillips, I. R. (2007) · Biochemical Journal · doi:10.1042/bj20070523 · Cited by 38 · see citing works

Metabolism of Toxicants

Rose, R. L., & Hodgson, E. (2004) · doi:10.1002/0471646776.ch7 · Cited by 38 · see citing works

HepaSH cells: Experimental human hepatocytes with lesser inter-individual variation and more sustainable availability than primary human hepatocytes

Uehara, S., Higuchi, Y., Yoneda, N., Ito, R., Takahashi, T., Murayama, N., Yamazaki, H., Murai, K., Hikita, H., Takehara, T., et al. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.04.054 · Cited by 37 · see citing works

Effect of Flavin-Containing Monooxygenase Genotype, Mouse Strain, and Gender on Trimethylamine N-oxide Production, Plasma Cholesterol Concentration, and an Index of Atherosclerosis

Veeravalli, S., Karu, K., Scott, F. H., Fennema, D., Phillips, I. R., & Shephard, E. A. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.077636 · Cited by 38 · see citing works

The Flavin-Containing Monoooxygenases (FMOs): Genetic Variation and its Consequences for the Metabolism of Therapeutic Drugs

Phillips, I. R., Francois, A. A., & Shephard, E. A. (2007) · Current Pharmacogenomics · doi:10.2174/157016007782793683 · Cited by 37 · see citing works

Clinical utility gene card for: Trimethylaminuria – update 2014

Shephard, E. A., Treacy, E. P., & Phillips, I. R. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.226 · Cited by 37 · see citing works

Molecular and functional characterization of flavin-containing monooxygenases in cynomolgus macaque

Uno, Y., Shimizu, M., & Yamazaki, H. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.04.012 · Cited by 36 · see citing works

Non-cytochrome P450-mediated bioactivation and its toxicological relevance

Gan, J., Ma, S., & Zhang, D. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1225756 · Cited by 35 · see citing works

Developmental Expression of the Cytosolic Sulfotransferases in Human Liver

Dubaisi, S., Caruso, J. A., Gaedigk, R., Vyhlidal, C. A., Smith, P. C., Hines, R. N., Kocarek, T. A., & Runge‐Morris, M. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.086363 · Cited by 35 · see citing works

Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions

Rendić, S., Crouch, R. D., & Guengerich, F. P. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03304-3 · Cited by 34 · see citing works

Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3)

Allerston, C. K., Shimizu, M., Fujieda, M., Shephard, E. A., Yamazaki, H., & Phillips, I. R. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328256b198 · Cited by 33 · see citing works

The Biochemistry of Drug Metabolism – An Introduction

Krämer, S. D., & Testa, B. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900233 · Cited by 33 · see citing works

Emerging epigenetic dynamics in gut-microglia brain axis: experimental and clinical implications for accelerated brain aging in schizophrenia

Ben‐Azu, B., del Re, E. C., VanderZwaag, J., Carrier, M., Keshavan, M. S., Khakpour, M., & Tremblay, M. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1139357 · Cited by 32 · see citing works

RNA-Sequencing Quantification of Hepatic Ontogeny of Phase-I Enzymes in Mice

Peng, L., Cui, J. Y., Yoo, B., Gunewardena, S., Lü, H., Klaassen, C. D., & Zhong, X. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054635 · Cited by 32 · see citing works

Functional activity of the mouse flavin‐containing monooxygenase forms 1, 3, and 5

Zhang, J., Cerny, M. A., Lawson, M., Mosadeghi, R., & Cashman, J. R. (2007) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20176 · Cited by 32 · see citing works

Inter-individual Variation in Flavin-containing Monooxygenase 3 in Livers from Japanese: Correlation with Hepatic Transcription Factors

Nagashima, S., Shimizu, M., Yano, H., Murayama, N., Kumai, T., Kobayashi, S., Guengerich, F. P., & Yamazaki, H. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.218 · Cited by 32 · see citing works

Sex-specific gene expression in the BXD mouse liver.

Gatti, D. M., Zhao, N., Chesler, E., Bradford, B., Shabalin, A., Yordanova, R., Lu, L., & Rusyn, I. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00110.2009 · Cited by 32 · see citing works

Developmental variations in metabolic capacity of flavin‐containing mono‐oxygenase 3 in childhood

Shimizu, M., Denton, T. T., Kozono, M., Cashman, J. R., Leeder, J. S., & Yamazaki, H. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03876.x · Cited by 31 · see citing works

Principles of Drug Metabolism 1: Redox Reactions

Trager, W. F. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00119-x · Cited by 32 · see citing works

Differential developmental and tissue-specific regulation of expression of the genes encoding three members of the flavin-containing monooxygenase family of man, FMO1, FM03 and FM04

Dolphin, C., Cullingford, T., Shephard, E., Smith, R., & Phillips, I. (1996) · UCL Discovery (University College London)

Differential Developmental and Tissue‐Specific Regulation of Expression of the Genes Encoding Three Members of the Flavin‐Containing Monooxygenase Family of Man, FMO1, FMO3 and FMO4

Dolphin, C. T., Cullingford, T. E., Shcphard, E. A., Smith, R. L., & Phillips, I. R. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00683.x · Cited by 152 · see citing works

Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3

Hines, R. N. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.1.41 · Cited by 42 · see citing works

Developmental regulation of flavin-containing monooxygenase form 1 in the liver and kidney of fetal and neonatal rabbits

Larsen-Su, S. A., Krueger, S. K., Yueh, M., Pereira, C. B., & Williams, D. E. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00872-9 · Cited by 3 · see citing works

Physiological factors affecting protein expression of flavin-containing monooxygenases 1, 3 and 5

Cherrington, N. J., Cao, Y., Cherrington, J. W., Rose, R. L., & Hodgson, E. (1998) · Xenobiotica · doi:10.1080/004982598239254 · Cited by 82 · see citing works